Current Evaluation of Amenorrhea

    July 2004 in “ Fertility and Sterility
    Image of study
    TLDR Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
    The 2004 document discussed the evaluation of amenorrhea, a condition where a woman of reproductive age doesn't have menstrual periods. It indicated that primary amenorrhea is when menstruation hasn't started by age 15 with normal secondary sexual development, or within five years after breast development if it starts before age 10. Secondary amenorrhea is when menstruation stops for three months, and oligomenorrhea is less than nine cycles a year. The prevalence of amenorrhea not due to pregnancy, lactation, or menopause was about 3% to 4%. The four main causes were polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure. Other causes were rare in a typical reproductive medicine practice. The World Health Organization grouped the causes based on evidence of endogenous estrogen production, normal or low FSH levels, normal prolactin levels, and no evidence of a lesion in the hypothalamic-pituitary region.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  445 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 6 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      21 citations, September 2004 in “Fertility and Sterility”
      Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.
      Androgen Treatment of Postmenopausal Women

      research Androgen Treatment of Postmenopausal Women

      28 citations, May 2013 in “The Journal of Steroid Biochemistry and Molecular Biology”
      Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      38 citations, October 2006 in “Fertility and Sterility”
      The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      78 citations, November 2008 in “Fertility and Sterility”
      Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.